TVM Capital Life Science is a leading international venture capital firm established in 1984 as a spin-off from Techno. See sector focus and contact routes.
TVM Capital Life Science is a leading international venture capital firm established in 1984 as a spin-off from Techno Venture Management, now focusing exclusively on life science innovations with headquarters in Munich and Montreal. The firm executes a dual-pronged investment thesis spanning early-stage therapeutics via a single-asset company approach and differentiated commercial-stage medical technologies across biotech, digital health, medical devices, and diagnostics. Its geographic scope covers Europe, North America, and Asia, targeting companies from the discovery phase through to market-ready and profitable growth stages. While specific typical check sizes are not explicitly detailed in public profiles, the firm recently led a €23 million Series C financing round for Smart Reporting, indicating capacity for significant follow-on investments. Notable portfolio companies include Smart Reporting, a medical reporting technology pioneer, alongside a diverse portfolio of over 130 life science companies invested in since inception across Europe, Canada, and the United States. The firm distinguishes itself with a 25-year transatlantic track record and
StartupFundraising tracks this firm record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to comparable investors.
Investors like TVM Capital Life Science · Full investor directory · Investor access · Company funding database